Jerome Groopman

Researchers have reported that a combination of drugs can greatly reduce the amount of HIV in the human bloodstream— sometimes to undetectable levels. In the following viewpoint, Jerome Groopman argues that a combination of AZT, 3TC, and a protease inhibitor can both reduce HIV levels and bolster the human immune system. Groopman is a professor of medicine at Harvard University Medical School and the director of the Mapplethorpe Laboratory for AIDS Research at Beth-Israel Deaconess Hospital, both in Boston.

As you read, consider the following questions:

1. How has HIV reacted to treatments applied against it, according to Groopman?
2. According to Groopman, what are “sanctuary sites”?
3. How are computers being used to help inhibit the integrase enzyme, according to the author"

The AIDS Conference held in July 1996 in Vancouver celebrated a turning point...